Evasc Neurovascular Enterprises

Founded in 2001 by co-founder and chief executive officer Donald Ricci, Evasc Neurovascular Enterprises is a Vancouver, British Columbia medical device company developing endovascular repair systems for treating cerebral aneurysms. The enterprise supplies neurosurgical and interventional neuroradiology practices with its proprietary eCLIPs Bifurcation Aneurysm Remodeling System, which specifically targets wide-neck bifurcations to provide flow diversion and endothelial growth. Alongside Chief Technology Officer Fernando Lopes, the organization has achieved significant clinical milestones, including enrolling patients in the French EESIS-FR safety and efficacy study and securing device approval through France’s Forfait Innovation program. Operating with an estimated 21 to 50 employees, the growing business generates approximately four million five hundred thousand dollars in annual revenue. The company reached a valuation of 14,400,000 dollars after securing 7,530,000 dollars in Series A venture financing led by institutional investor Yonghua Capital.